3-iodobenzylguanidine has been researched along with Peripheral Nervous System Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Becker, G; Benecke, R; Braune, S; Büttner, T; Greulich, W; Klein, W; Mark, G; Müller, A; Rieke, J; Thümler, R | 1 |
Becerra García, D; Escobar Jiménez, F; Fernández Fernández, B; Fernández Soto, M; Lumbreras Vega, L; Martínez Sampere, JJ; Nevado Jiménez, A; Nieto Serrano, R | 1 |
Hwang, EH; Komai, K; Matsunari, I; Nakajima, K; Sakajiri, K; Taki, J; Tonami, N; Yoshita, M | 1 |
1 review(s) available for 3-iodobenzylguanidine and Peripheral Nervous System Diseases
Article | Year |
---|---|
Early diagnosis of Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Affect; Biomarkers; Handwriting; Heart; Humans; Iron; Mood Disorders; Movement Disorders; Mutation; Olfaction Disorders; Parkinson Disease; Peripheral Nervous System Diseases; Psychomotor Performance; Radiopharmaceuticals; Risk Assessment; Risk Factors; Speech; Substantia Nigra; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ultrasonography; Vision, Ocular | 2002 |
1 trial(s) available for 3-iodobenzylguanidine and Peripheral Nervous System Diseases
Article | Year |
---|---|
Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp.
Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Coronary Circulation; Female; Heart; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardium; Parkinson Disease; Peripheral Nervous System Diseases; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2000 |
1 other study(ies) available for 3-iodobenzylguanidine and Peripheral Nervous System Diseases
Article | Year |
---|---|
[Evaluation of cardiac sympathetic innervation with 123I-metaiodobenzylguanidine in patients with diabetes mellitus].
Topics: 3-Iodobenzylguanidine; Adult; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Heart; Humans; Male; Peripheral Nervous System Diseases; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 1998 |